Zhong Guo Zheng Quan Bao - Zhong Zheng Wang·2025-10-22 01:07Group 1 - The announcement details the change of fund manager and the participation of certain public funds managed by the company in the offline subscription of Guangzhou Bibete Pharmaceutical Co., Ltd.'s initial public offering (IPO) [1][2] - The IPO price for Bibete is set at RMB 17.78 per share, determined through a comprehensive assessment of the issuer's fundamentals, market conditions, and underwriting risks [1] - The company confirms compliance with relevant regulations and has reported the fund manager change to the China Securities Investment Fund Industry Association and the Shenzhen Regulatory Bureau of the China Securities Regulatory Commission [1] Group 2 - The announcement includes information about the public REITs, specifically the lifting of restrictions on fund shares, with 239,150,000 shares (47.83% of total shares) set to be released from lock-up on October 23, 2025 [4] - Prior to the lifting of restrictions, the fund had 135,850,000 shares (27.17% of total shares) available for trading in the secondary market [4] - After the lifting of restrictions, the total tradable shares will increase to 375,000,000, representing 75.00% of the total fund shares [4] Group 3 - The fund holds two rental housing projects in Shenzhen, with a total of 927 rental units and 15 commercial units, covering a rental area of 65,253.27 square meters [10] - As of June 30, 2025, the overall occupancy rate of the projects is 95.08%, with a rent collection rate of 98.47% [10] - The fund's cumulative distributable amount from September 26, 2024, to June 30, 2025, is reported to be RMB 43,406,468.39 [11] Group 4 - The market price of the fund on October 21, 2025, was RMB 3.529 per share, reflecting a 29.41% increase from the issue price [11] - The predicted distributable amount for 2025 is RMB 55,221,333.85, with different net cash flow distribution rates calculated based on the purchase price [12][13] - The net cash flow distribution rate for an investor buying at the issue price of RMB 2.727 per share is projected at 4.05%, while for a purchase at the market price of RMB 3.529, it is projected at 3.13% [12][13]